Moximed Inc. is dedicated to developing minimally invasive joint-sparing solutions for patients suffering from knee osteoarthritis. Their flagship product, the MISHA Knee System, is an implantable shock absorber designed to unload the knee, relieve pain, and improve function. This innovative approach allows for quick recovery times, enabling patients to resume normal activities within days. Moximed serves a global market, providing advanced healthcare solutions to improve the quality of life for individuals with knee OA.
Moximed has made significant strides in the field of orthopedic medical devices, particularly with the successful implementation of the MISHA Knee System. The company's impact is evident in its ability to offer a new treatment paradigm for managing knee osteoarthritis, which has benefited numerous patients worldwide. Through their pioneering technology and commitment to patient care, Moximed continues to lead advancements in minimally invasive orthopedic solutions.
